Brown Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261M Buy
1,028,187
+28,548
+3% +$6.65M 0.4% 53
2026
Q1
$244M Buy
999,639
+15,132
+2% +$3.52M 0.4% 60
2025
Q4
$204M Buy
984,507
+28,392
+3% +$5.61M 0.28% 70
2025
Q3
$177M Sell
956,115
-7,788
-0.8% -$1.33M 0.23% 81
2025
Q2
$147M Sell
963,903
-12,478
-1% -$1.92M 0.19% 89
2025
Q1
$162M Sell
976,381
-10,633
-1% -$1.66M 0.23% 82
2024
Q4
$143M Sell
987,014
-18,391
-2% -$2.85M 0.18% 101
2024
Q3
$163M Buy
1,005,405
+5,900
+0.6% +$940K 0.2% 84
2024
Q2
$146M Buy
999,505
+9,552
+1% +$1.42M 0.19% 90
2024
Q1
$157M Sell
989,953
-21,776
-2% -$3.47M 0.21% 90
2023
Q4
$159M Buy
1,011,729
+5,233
+0.5% +$802K 0.22% 88
2023
Q3
$157M Sell
1,006,496
-64,401
-6% -$10.6M 0.26% 84
2023
Q2
$177M Sell
1,070,897
-2,308
-0.2% -$373K 0.28% 78
2023
Q1
$166M Sell
1,073,205
-18,152
-2% -$2.93M 0.28% 83
2022
Q4
$193M Buy
1,091,357
+4,897
+0.5% +$846K 0.36% 69
2022
Q3
$177M Buy
1,086,460
+24,220
+2% +$4.1M 0.35% 69
2022
Q2
$189M Buy
1,062,240
+11,370
+1% +$2.03M 0.35% 68
2022
Q1
$186M Sell
1,050,870
-125,291
-11% -$21.3M 0.28% 82
2021
Q4
$201M Buy
1,176,161
+119,252
+11% +$19.5M 0.25% 83
2021
Q3
$171M Sell
1,056,909
-16,535
-2% -$2.82M 0.25% 84
2021
Q2
$177M Buy
1,073,444
+1,890
+0.2% +$313K 0.27% 82
2021
Q1
$176M Sell
1,071,554
-29,130
-3% -$4.71M 0.3% 79
2020
Q4
$173M Sell
1,100,684
-9,627
-0.9% -$1.42M 0.31% 74
2020
Q3
$165M Buy
1,110,311
+11,144
+1% +$1.65M 0.34% 73
2020
Q2
$155M Buy
1,099,167
+1,232
+0.1% +$180K 0.36% 68
2020
Q1
$144M Buy
1,097,935
+10,589
+1% +$1.5M 0.44% 53
2019
Q4
$159M Sell
1,087,346
-15,348
-1% -$2.08M 0.4% 54
2019
Q3
$143M Sell
1,102,694
-18,308
-2% -$2.41M 0.4% 56
2019
Q2
$156M Sell
1,121,002
-211,031
-16% -$29.2M 0.45% 52
2019
Q1
$186M Sell
1,332,033
-10,521
-0.8% -$1.41M 0.53% 46
2018
Q4
$173M Sell
1,342,554
-30,921
-2% -$4.31M 0.58% 43
2018
Q3
$190M Sell
1,373,475
-3,034
-0.2% -$403K 0.54% 45
2018
Q2
$167M Buy
1,376,509
+94,776
+7% +$11.8M 0.51% 45
2018
Q1
$164M Sell
1,281,733
-92,363
-7% -$12.5M 0.53% 46
2017
Q4
$192M Sell
1,374,096
-14,164
-1% -$1.97M 0.61% 48
2017
Q3
$180M Sell
1,388,260
-123,053
-8% -$16.3M 0.6% 46
2017
Q2
$200M Buy
1,511,313
+150,029
+11% +$19.1M 0.61% 46
2017
Q1
$170M Sell
1,361,284
-19,911
-1% -$2.38M 0.58% 47
2016
Q4
$159M Buy
1,381,195
+40,755
+3% +$4.71M 0.57% 48
2016
Q3
$158M Buy
1,340,440
+24,678
+2% +$2.99M 0.54% 51
2016
Q2
$160M Buy
1,315,762
+65,386
+5% +$7.43M 0.56% 48
2016
Q1
$135M Buy
1,250,376
+98,273
+9% +$10.2M 0.47% 50
2015
Q4
$118M Buy
1,152,103
+34,008
+3% +$3.42M 0.4% 54
2015
Q3
$104M Buy
1,118,095
+37,337
+3% +$3.61M 0.37% 55
2015
Q2
$105M Sell
1,080,758
-2,863
-0.3% -$287K 0.34% 55
2015
Q1
$109M Buy
1,083,621
+24,669
+2% +$2.51M 0.35% 55
2014
Q4
$111M Sell
1,058,952
-445
-0% -$46.9K 0.35% 57
2014
Q3
$113M Buy
1,059,397
+2,163
+0.2% +$224K 0.36% 51
2014
Q2
$111M Sell
1,057,234
-34,801
-3% -$3.52M 0.35% 46
2014
Q1
$107M Sell
1,092,035
-12,916
-1% -$1.2M 0.34% 45
2013
Q4
$101M Sell
1,104,951
-5,820
-0.5% -$536K 0.33% 47
2013
Q3
$96.3M Buy
1,110,771
+9,407
+0.9% +$844K 0.34% 47
2013
Q2
$94.6M Buy
+1,101,364
New +$93.5M 0.38% 47

Other funds holding JNJ

Brown Advisory's JNJ Position: Q2 2026 in Review

Brown Advisory increased its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, buying an estimated $6.65M and bringing the position to 1,028,187 shares worth $261M. The position accounts for 0.4% of the portfolio, ranked #53.

Brown Advisory first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Brown Advisory held 1,028,187 shares of Johnson & Johnson worth $261M as of Q2 2026.
  • Brown Advisory bought 28,548 Johnson & Johnson shares in Q2 2026, an estimated $6.65M.
  • Johnson & Johnson made up 0.4% of Brown Advisory's portfolio in Q2 2026, its #53 holding.
  • Brown Advisory first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.